Damora Therapeutics (DMRA) EBIT (2019 - 2026)
Damora Therapeutics (DMRA) posted EBIT of -$30.8 million for Q1 2026, up 84.72% on a QoQ basis from -$201.7 million in Q4 2025, and down 1085.49% year-over-year from $3.1 million in Q1 2025.
Damora Therapeutics (DMRA) EBIT (2019 - 2026) Analysis & Trends
Damora Therapeutics' EBIT history runs 8 years deep, the most recent figure standing at -$30.8 million for Q1 2026.
- Quarterly EBIT fell 1085.49% year-over-year to -$30.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$239.1 million (down 1150.57% YoY) and the FY2025 annual result came in at -$210.9 million, down 847.31% from the prior year.
- EBIT was -$30.8 million for Q1 2026 at Damora Therapeutics, up from -$201.7 million in the prior quarter.
- Across five years, EBIT topped out at -$2.6 million in Q1 2025 and bottomed at -$201.7 million in Q4 2025.
- A 5-year average of -$21.5 million and a median of -$8.6 million in 2023 frame the typical range for EBIT.
- Annual changes were most pronounced in 2024 — EBIT jumped 57.45% — and 2025, when it plunged 2739.99%.
- Damora Therapeutics' EBIT stood at -$13.5 million in 2022, then soared by 50.68% to -$6.7 million in 2023, then declined by 6.46% to -$7.1 million in 2024, then plunged by 2739.99% to -$201.7 million in 2025, then jumped by 84.72% to -$30.8 million in 2026.
- Business Quant data shows DMRA's EBIT at -$30.8 million in Q1 2026, -$201.7 million in Q4 2025, and -$3.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Damora Therapeutics | 986.02 Mn | 783.62 Mn | - | -30.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.81 Mn |
| Dec 31, 2025 | -201.70 Mn |
| Sep 30, 2025 | -3.16 Mn |
| Jun 30, 2025 | -3.42 Mn |
| Mar 31, 2025 | -2.60 Mn |
| Dec 31, 2024 | -7.10 Mn |
| Sep 30, 2024 | -3.84 Mn |
| Jun 30, 2024 | -5.58 Mn |
| Mar 31, 2024 | -5.74 Mn |
| Dec 31, 2023 | -6.67 Mn |
| Sep 30, 2023 | -8.58 Mn |
| Jun 30, 2023 | -11.16 Mn |
| Mar 31, 2023 | -13.49 Mn |
| Dec 31, 2022 | -13.53 Mn |
| Sep 30, 2022 | -13.62 Mn |
| Jun 30, 2022 | -17.12 Mn |
| Mar 31, 2022 | -16.94 Mn |
| Dec 31, 2021 | -13.47 Mn |
| Sep 30, 2021 | -12.94 Mn |
| Jun 30, 2021 | -12.27 Mn |